We aimed to determine if an adolescent patient presenting with neurological impairment has xeroderma pigmentosum (XP). For this purpose, whole-exome sequencing was performed to assess mutations in genes. Dermal fibroblasts were established from a skin biopsy and XPA expression determined by immunoblotting.
View Article and Find Full Text PDF